by Admin | January 26, 2017 4:29 pm
January 26, 2017—Sen. Chuck Grassley (R-Iowa) is ramping up pressure on the Centers for Medicare and Medicaid Services to hand over documents about Mylan Pharmaceuticals’ misclassification of EpiPen as a generic drug and subsequent underpayment of Medicaid rebates.
Source URL: https://340binformed.org/2017/01/senator-slams-cms-response-to-questions-about-epipen/
Copyright ©2024 340binformed.org unless otherwise noted.